47 related articles for article (PubMed ID: 14989760)
1. [Methylation status of multidrug resistance (mdr1) gene and its correlation with expression of mdr1 gene in patients with hematologic malignancies].
Zhu Y; Wu SL; Bu DF; Li Y; Zhu Q; Cao XH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Feb; 12(1):6-10. PubMed ID: 14989760
[TBL] [Abstract][Full Text] [Related]
2. MDR1 gene overexpression and altered degree of methylation at the promoter region in bladder cancer during chemotherapeutic treatment.
Tada Y; Wada M; Kuroiwa K; Kinugawa N; Harada T; Nagayama J; Nakagawa M; Naito S; Kuwano M
Clin Cancer Res; 2000 Dec; 6(12):4618-27. PubMed ID: 11156211
[TBL] [Abstract][Full Text] [Related]
3. CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer.
Enokida H; Shiina H; Igawa M; Ogishima T; Kawakami T; Bassett WW; Anast JW; Li LC; Urakami S; Terashima M; Verma M; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
Cancer Res; 2004 Sep; 64(17):5956-62. PubMed ID: 15342374
[TBL] [Abstract][Full Text] [Related]
4. [Expression and clinical study of multidrug resistance gene and multidrug resistance associated protein gene in acute leukemia].
Ma J; Lai Y; Lu Y; Niu W
Zhonghua Nei Ke Za Zhi; 1999 Jan; 38(1):47-9. PubMed ID: 11798628
[TBL] [Abstract][Full Text] [Related]
5. Association of mdr1 gene expression with other prognostic factors and clinical outcome in human breast cancer.
Punyammalee B; Manoromana S; Purisa W; Chariyalertsak S; Rerkamnuaychok B
J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S162-73. PubMed ID: 9347665
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of ABCB1/P-glycoprotein by escaping promoter hypermethylation indicates poor prognosis in hematologic malignancy patients with and without bone marrow transplantation.
Shi CJ; Wang F; Ren MF; Mi YJ; Yan YY; To KK; Dai CL; Wang YS; Chen LM; Tong XZ; Liang YJ; Fu LW
Leuk Res; 2011 Jan; 35(1):73-9. PubMed ID: 20488541
[TBL] [Abstract][Full Text] [Related]
7. Altered methylation of the human MDR1 promoter is associated with acquired multidrug resistance.
Kantharidis P; El-Osta A; deSilva M; Wall DM; Hu XF; Slater A; Nadalin G; Parkin JD; Zalcberg JR
Clin Cancer Res; 1997 Nov; 3(11):2025-32. PubMed ID: 9815593
[TBL] [Abstract][Full Text] [Related]
8. Promoter methylation of glutathione S-transferase pi1 and multidrug resistance gene 1 in bronchioloalveolar carcinoma and its correlation with DNA methyltransferase 1 expression.
Gao P; Yang X; Xue YW; Zhang XF; Wang Y; Liu WJ; Wu XJ
Cancer; 2009 Jul; 115(14):3222-32. PubMed ID: 19484794
[TBL] [Abstract][Full Text] [Related]
9. Competitive reverse transcription-polymerase chain reaction assay for quantification of human multidrug resistance 1 (MDR1) gene expression in fresh leukemic cells.
Kobayashi H; Takemura Y; Kawai Y; Miyachi H; Kawabata M; Matsumura T; Yamashita T; Mori S; Furihata K; Shimodaira S; Motoyoshi K; Hotta T; Sekiguchi S; Ando Y; Watanabe K
J Lab Clin Med; 2000 Feb; 135(2):199-209. PubMed ID: 10695666
[TBL] [Abstract][Full Text] [Related]
10. Comparison of multidrug resistance gene expression levels with malignant potentials and influence of chemotherapy in urothelial cancers.
Kakehi Y; Wu WJ; Kim WJ; Arao S; Fukumoto M; Yoshida O
Int J Urol; 1995 Nov; 2(5):309-15. PubMed ID: 8749949
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of multidrug resistance gene(mdr1) expression in patients with acute leukemia].
Dong Z; Luo J; Xu W
Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):72-5. PubMed ID: 10743063
[TBL] [Abstract][Full Text] [Related]
12. Semiquantitative RT-PCR evaluation of the MDR1 gene expression in patients with acute myeloid leukemia.
Trnková Z; Bedrlíková R; Marková J; Michalová K; Stöckbauer P; Schwarz J
Neoplasma; 2007; 54(5):383-90. PubMed ID: 17688368
[TBL] [Abstract][Full Text] [Related]
13. 5-Azacytidine modulates the response of sensitive and multidrug-resistant K562 leukemic cells to cytostatic drugs.
Efferth T; Futscher BW; Osieka R
Blood Cells Mol Dis; 2001; 27(3):637-48. PubMed ID: 11482878
[TBL] [Abstract][Full Text] [Related]
14. [Study on DNA methylation status of WT1 gene in its promoter region in hematologic malignancy cell lines].
Zhao Y; Chen ZX; Hu SY; Cen JN; Gu WY
Zhonghua Xue Ye Xue Za Zhi; 2005 Sep; 26(9):517-20. PubMed ID: 16468326
[TBL] [Abstract][Full Text] [Related]
15. Clinical relationship between MDR1 gene and gallbladder cancer.
Wang BL; Zhai HY; Chen BY; Zhai SP; Yang HY; Chen XP; Zhao WT; Meng L
Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):296-9. PubMed ID: 15138130
[TBL] [Abstract][Full Text] [Related]
16. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
[TBL] [Abstract][Full Text] [Related]
17. MDR1 gene expression in primary and advanced breast cancer.
Yang X; Uziely B; Groshen S; Lukas J; Israel V; Russell C; Dunnington G; Formenti S; Muggia F; Press MF
Lab Invest; 1999 Mar; 79(3):271-80. PubMed ID: 10092063
[TBL] [Abstract][Full Text] [Related]
18. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
19. Biological and clinical significance of concurrent p53 gene alterations, MDR1 gene expression, and S-phase fraction analyses in breast cancer patients treated with primary chemotherapy or radiotherapy.
Chevillard S; Lebeau J; Pouillart P; de Toma C; Beldjord C; Asselain B; Klijanienko J; Fourquet A; Magdelénat H; Vielh P
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2471-8. PubMed ID: 9815649
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of multidrug-resistance mdr1 gene expression in head and neck cancer by real-time RT-PCR.
Tseng CP; Cheng AJ; Chang JT; Tseng CH; Wang HM; Liao CT; Chen IH; Tseng KC
Jpn J Cancer Res; 2002 Nov; 93(11):1230-6. PubMed ID: 12460464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
